Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Aspiration pneumonia after chemo-intensity-modulated radiation therapy of oropharyngeal carcinoma and its clinical and dysphagia-related predictors.

Hunter KU, Lee OE, Lyden TH, Haxer MJ, Feng FY, Schipper M, Worden F, Prince ME, McLean SA, Wolf GT, Bradford CR, Chepeha DB, Eisbruch A.

Head Neck. 2014 Jan;36(1):120-5. doi: 10.1002/hed.23275. Epub 2013 Jun 1.

2.

Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results.

Feng FY, Kim HM, Lyden TH, Haxer MJ, Worden FP, Feng M, Moyer JS, Prince ME, Carey TE, Wolf GT, Bradford CR, Chepeha DB, Eisbruch A.

J Clin Oncol. 2010 Jun 1;28(16):2732-8. doi: 10.1200/JCO.2009.24.6199. Epub 2010 Apr 26.

3.

Toxicities affecting quality of life after chemo-IMRT of oropharyngeal cancer: prospective study of patient-reported, observer-rated, and objective outcomes.

Hunter KU, Schipper M, Feng FY, Lyden T, Haxer M, Murdoch-Kinch CA, Cornwall B, Lee CS, Chepeha DB, Eisbruch A.

Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):935-40. doi: 10.1016/j.ijrobp.2012.08.030. Epub 2012 Oct 3.

4.

Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates.

Eisbruch A, Kim HM, Feng FY, Lyden TH, Haxer MJ, Feng M, Worden FP, Bradford CR, Prince ME, Moyer JS, Wolf GT, Chepeha DB, Ten Haken RK.

Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):e93-9. doi: 10.1016/j.ijrobp.2010.12.067. Epub 2011 May 17.

5.

Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures.

Feng FY, Kim HM, Lyden TH, Haxer MJ, Feng M, Worden FP, Chepeha DB, Eisbruch A.

Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1289-98. Epub 2007 Jun 7.

PMID:
17560051
6.

Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT?

Eisbruch A, Schwartz M, Rasch C, Vineberg K, Damen E, Van As CJ, Marsh R, Pameijer FA, Balm AJ.

Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1425-39.

PMID:
15590174
7.

Long-term quality of life after swallowing and salivary-sparing chemo-intensity modulated radiation therapy in survivors of human papillomavirus-related oropharyngeal cancer.

Vainshtein JM, Moon DH, Feng FY, Chepeha DB, Eisbruch A, Stenmark MH.

Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):925-33. doi: 10.1016/j.ijrobp.2014.12.045.

PMID:
25832685
8.

Reducing xerostomia after chemo-IMRT for head-and-neck cancer: beyond sparing the parotid glands.

Little M, Schipper M, Feng FY, Vineberg K, Cornwall C, Murdoch-Kinch CA, Eisbruch A.

Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):1007-14. doi: 10.1016/j.ijrobp.2011.09.004. Epub 2011 Nov 4.

9.

Patient-reported voice and speech outcomes after whole-neck intensity modulated radiation therapy and chemotherapy for oropharyngeal cancer: prospective longitudinal study.

Vainshtein JM, Griffith KA, Feng FY, Vineberg KA, Chepeha DB, Eisbruch A.

Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):973-80. doi: 10.1016/j.ijrobp.2014.03.013. Epub 2014 May 3.

PMID:
24803039
10.

Can IMRT or brachytherapy reduce dysphagia associated with chemoradiotherapy of head and neck cancer? The Michigan and Rotterdam experiences.

Eisbruch A, Levendag PC, Feng FY, Teguh D, Lyden T, Schmitz PI, Haxer M, Noever I, Chepeha DB, Heijmen BJ.

Int J Radiat Oncol Biol Phys. 2007;69(2 Suppl):S40-2.

11.

Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy.

Schwartz DL, Hutcheson K, Barringer D, Tucker SL, Kies M, Holsinger FC, Ang KK, Morrison WH, Rosenthal DI, Garden AS, Dong L, Lewin JS.

Int J Radiat Oncol Biol Phys. 2010 Dec 1;78(5):1356-65. doi: 10.1016/j.ijrobp.2009.10.002. Epub 2010 Jun 18.

12.

Prospective functional outcomes in sequential population based cohorts of stage III/ IV oropharyngeal carcinoma patients treated with 3D conformal vs. intensity modulated radiotherapy.

Kerr P, Myers CL, Butler J, Alessa M, Lambert P, Cooke AL.

J Otolaryngol Head Neck Surg. 2015 May 13;44:17. doi: 10.1186/s40463-015-0068-4.

13.

Dysphagia and trismus after concomitant chemo-Intensity-Modulated Radiation Therapy (chemo-IMRT) in advanced head and neck cancer; dose-effect relationships for swallowing and mastication structures.

van der Molen L, Heemsbergen WD, de Jong R, van Rossum MA, Smeele LE, Rasch CR, Hilgers FJ.

Radiother Oncol. 2013 Mar;106(3):364-9. doi: 10.1016/j.radonc.2013.03.005. Epub 2013 Mar 26.

PMID:
23540551
14.

Lhermitte sign after chemo-IMRT of head-and-neck cancer: incidence, doses, and potential mechanisms.

Pak D, Vineberg K, Feng F, Ten Haken RK, Eisbruch A.

Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1528-33. doi: 10.1016/j.ijrobp.2011.10.052. Epub 2012 Jan 26.

15.

Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer.

Eisbruch A, Lyden T, Bradford CR, Dawson LA, Haxer MJ, Miller AE, Teknos TN, Chepeha DB, Hogikyan ND, Terrell JE, Wolf GT.

Int J Radiat Oncol Biol Phys. 2002 May 1;53(1):23-8.

PMID:
12007937
16.

Gastrostomy tube placement in patients with oropharyngeal carcinoma treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence.

Bhayani MK, Hutcheson KA, Barringer DA, Lisec A, Alvarez CP, Roberts DB, Lai SY, Lewin JS.

Head Neck. 2013 Nov;35(11):1634-40. doi: 10.1002/hed.23200. Epub 2013 Jan 16.

PMID:
23322563
17.

A multi-institution pooled analysis of gastrostomy tube dependence in patients with oropharyngeal cancer treated with definitive intensity-modulated radiotherapy.

Setton J, Lee NY, Riaz N, Huang SH, Waldron J, O'Sullivan B, Zhang Z, Shi W, Rosenthal DI, Hutcheson KA, Garden AS.

Cancer. 2015 Jan 15;121(2):294-301. doi: 10.1002/cncr.29022. Epub 2014 Oct 6.

18.

Practical considerations in reducing swallowing dysfunction following concurrent chemoradiotherapy with intensity-modulated radiotherapy for head and neck cancer.

Batth SS, Caudell JJ, Chen AM.

Head Neck. 2014 Feb;36(2):291-8. doi: 10.1002/hed.23246. Epub 2013 Mar 18. Review.

PMID:
23508721
19.

Dysphagia in head and neck cancer patients following intensity modulated radiotherapy (IMRT).

Peponi E, Glanzmann C, Willi B, Huber G, Studer G.

Radiat Oncol. 2011 Jan 5;6:1. doi: 10.1186/1748-717X-6-1.

20.

Swallowing outcomes in patients with oropharyngeal cancer undergoing organ-preservation treatment.

Starmer HM, Tippett D, Webster K, Quon H, Jones B, Hardy S, Gourin CG.

Head Neck. 2014 Oct;36(10):1392-7. doi: 10.1002/hed.23465. Epub 2014 Jan 13.

PMID:
24038454
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk